Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study.

scientific article published in October 1994

Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0168-8278(94)80092-8
P698PubMed publication ID7814794

P2093author name stringBurroughs AK
McCormick PA
McIntyre N
Scheuer PJ
Epstein O
Scott F
P2860cites workA multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Effect of stanozolol on itching in primary biliary cirrhosisQ34166986
Opioid peptides and primary biliary cirrhosisQ35706319
Immunosupressive therapy for primary biliary cirrhosisQ36767051
Classification of chronic viral hepatitis: a need for reassessmentQ37032966
Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosisQ39642410
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditionsQ40344888
Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluationQ42205727
Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosusQ42259263
Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis.Q44573504
Treatment of erythema nodosum leprosum with thalidomide.Q53993902
Thalidomide in actinic prurigoQ56785080
Thalidomide for the treatment of chronic graft-versus-host diseaseQ68075890
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosisQ68505504
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trialQ69357047
A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone lossQ69721905
Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantationQ69910910
Thalidomide for graft-versus-host diseaseQ69926191
Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host diseaseQ72424956
The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomaliesQ79447470
Thalidomide in hyperalgic pharyngeal ulceration of AIDSQ93509771
The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomaliesQ94293605
P433issue4
P921main subjectplaceboQ269829
primary biliary cholangitisQ1072420
P304page(s)496-499
P577publication date1994-10-01
P1433published inJournal of HepatologyQ15724402
P1476titleThalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study.
P478volume21

Reverse relations

cites work (P2860)
Q46509129A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue
Q33591450Bile acid abnormalities in cholestatic liver diseases
Q37618589Diagnosis and Management of Chronic Pruritus: An Expert Consensus Review
Q42590864Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid
Q34936778Evolving new therapies of autoimmune hepatitis
Q35960781Management of primary biliary cirrhosis and autoimmune cholangitis
Q37355843Natural history and management of primary biliary cirrhosis
Q38738566Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Q24186852Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis
Q21202919Primary biliary cirrhosis
Q56854243Primary biliary cirrhosis
Q26853649Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy
Q32111479Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing
Q55333522Update on pharmacotherapies for cholestatic liver disease.

Search more.